On Wednesday, September 11, quotes on Gatekeeper Systems, a Canada-based solutions provider for public transportation and smart cities, <a href="https://finance.yahoo.com/quote/GSI.V/">surged</a> about 20% in Toronto and New York. The trigger was preliminary financial results for the fiscal-2024 fourth quarter and full year (ended August 31), which <a href="https://www.gatekeeper-systems.com/news/gatekeeper-reports-preliminary-fiscal-q4-revenue-of-11-5m-and-2024-fiscal-annual-revenue-of-37-6m/">showed</a> record revenue.

Smart city solutions provider Gatekeeper gains on preliminary financials

Shares of telecom company AST SpaceMobile, which aims to compete with Elon Musk's SpaceX, have skyrocketed over 1,300% since April, when they hit an all-time low. The growth makes AST SpaceMobile the top-performing stock in the small-cap Russell 2000 index over the last six months, Bloomberg <a href="https://www.bloomberg.com/news/articles/2024-09-11/spacex-s-tiny-rival-soars-1-300-now-comes-the-satellite-launch?sref=Y0jVLcFo">reports</a>. The latest gains are attributable to the launch of the company’s first satellites today, Thursday, September 12.

Shares of SpaceX's small competitor now up over 1,300% since April

Zacks Small-Cap Research has released a report on Tonix Pharmaceuticals, which is developing a monkeypox vaccine, <a href="https://s27.q4cdn.com/906368049/files/News/2024/Zacks_SCR_Research_09092024_TNXP_Bautz.pdf">valuing</a> the stock at $4 per share, nearly 26 times the last closing price. The company's current market capitalization is around $3.3 million.

Micro-cap Tonix Pharmaceuticals massively undervalued amid monkeypox outbreak — Zacks

Small-cap stocks may be poised for a big rally in the next 6-12 months, <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/09/40794070/exclusive-lazard-small-cap-expert-predicts-30-50-russell-2000-rally-on-the-back-of-">according</a> to Sean Gallagher, who oversees investments in the asset class at Lazard. He estimates that the Russell 2000 index could gain as much as 30-50% amid Fed rate cuts.

Russell 2000 set to rally amid Fed rate cuts – Lazard

Canada’s Lexaria Bioscience, with a market capitalization of just over $50 million on the Nasdaq, is in the business of transforming the delivery of other companies' drugs. After years of trying to find its niche, the company now intends to make globally best-selling injectable diabetes and obesity drugs from Novo Nordisk and Eli Lilly, like Wegovy and Zepbound, into pills using its patented technology. This new focus has already massively boosted Lexaria stock since the beginning of the year.

Best-selling drugs in pill form: How Lexaria plans to make it big on weight-loss wave

Shares of Terns Pharmaceuticals, a biotech company with a market capitalization of $641.8 million, surged nearly 17% on Monday, September 9. The trigger was clinical trial results <a href="https://finance.yahoo.com/news/terns-pharmaceuticals-announces-positive-phase-110500652.html">showing</a> that more than half of the patients using the highest dose of the company's oral weight-loss drug lost 5% of their body weight in just one month, <a href="https://www.barrons.com/articles/terns-pharmaceuticals-stock-weight-loss-pill-23f9c5c2?mod=hp_DAY_Theme_1_2">reports</a> . Terns is vying for a share of the weight-loss drug market, which is currently dominated by Eli Lilly and Novo Nordisk.

Terns stock rises on positive early trial of obesity pill

Quotes on Mama’s Creations, a maker of pre-prepared foods with a market capitalization of $298.1 million, <a href="https://www.nasdaq.com/market-activity/stocks/mama">rose</a> 4.6% on Monday, September 9. Earlier in the day, the company <a href="https://ir.mamascreations.com/mamas-creations-appoints-veteran-supply-chain-and-operations-leader-skip-tappan-as-chief-operating-officer/">announced</a> that Skip Tappan, a manager with experience at Walmart, Procter &amp; Gamble, and Campbell Soup, would be taking over as COO. He is expected to prepare the company "for future acquisitions and integrations."

Shares of pre-prepared food maker Mama’s Creations rise after new COO announced

The global shift toward digitalization is creating opportunities across various markets as companies integrate AI, machine learning, and blockchain technologies. Zacks has <a href="https://www.zacks.com/commentary/2332562/3-stocks-to-buy-from-the-flourishing-technology-services-market">fingered</a> three stocks that could benefit from the rapid growth in what it calls the technology services market: the small caps Byrna Technologies and Climb Global Solutions, as well as the giant Spotify Technology.

Zacks spotlights three stocks poised to benefit from booming tech services market

SatixFy, an Israeli company with a market capitalization of $60.4 million that develops satellite communication systems, has reported that its net loss more than halved year over year in the first half of 2024. Revenue rose 7% as the company shifted from development and preproduction to product sales. Quotes on SatixFy <a href="https://finance.yahoo.com/quote/SATX/">dipped</a> 1% on the NYSE on Friday, September 6.

Satellite communication systems maker SatixFy halves net loss in first half

On Thursday, September 5, quotes on late-stage pharmaceutical company Citius Oncology <a href="https://finance.yahoo.com/quote/CTOR/">added</a> more than 8%. The company <a href="https://citiuspharma.com/investors/news-media/news/release-details/2024/Citius-Pharmaceuticals-Inc.-and-Citius-Oncology-Inc.-Announce-LYMPHIR-Denileukin-Diftitox-cxdl-Added-to-National-Comprehensive-Cancer-Network-NCCN-Clinical-Practice-Guidelines-in-Oncology/default.aspx">announced</a> that its only approved drug so far, LYMPHIR, made to treat lymphoma, had been added to clinical practice guidelines in oncology, which makes it easier for doctors to prescribe and for insurers to cover the drug.

Citius Oncology stock jumps after its drug included in clinical guidelines

The U.S. company PSQ Holdings, also known as PublicSquare, brands itself as a marketplace for family-oriented, patriotic and politically conservative Americans. Three years ago, it was just an idea, a few lines of code, and seven employees. "We will become the new Amazon," <a href="https://www.iwf.org/2023/07/07/michael-seifert-boycotts-and-shopping-at-businesses-that-align-with-your-values/">proclaims</a> its founder, Michael Seifert. While the business has indeed grown significantly since its inception, PSQ has yet to turn a profit and recently saw downward revisions to analyst performance forecasts.

Amazon for patriots: How PSQ Holdings is monetizing Trump campaign slogans

On Wednesday, September 4, display manufacturer Daktronics saw its stock drop more than 9% after releasing previous-quarter financials. Sales <a href="https://investor.daktronics.com/news-releases/news-release-details/daktronics-inc-announces-2025-fiscal-first-quarter-results">fell</a> 2.8% year over year, while earnings per share missed analysts' expectations.

Small caps